Nike (NKE) Offering Possible 12.87% Return Over the Next 24 Calendar Days

Nike's most recent trend suggests a bullish bias. One trading opportunity on Nike is a Bull Put Spread using a strike $95.00 short put and a strike $90.00 long put offers a potential 12.87% return on risk over the next 24 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $95.00 by expiration. The full premium credit of $0.57 would be kept by the premium seller. The risk of $4.43 would be incurred if the stock dropped below the $90.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for Nike is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Nike is bullish.

The RSI indicator is at 77.3 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for Nike

A streaky year in apparel and investing
Fri, 20 Dec 2019 22:48:33 +0000
The biggest company in Oregon generated headlines throughout 2019, but Nike wasn't the only important story among the state's banks and apparel companies.

Stock Market Live Updates: Stocks stretch to new records; United Steel plunges on layoffs, profit warning
Fri, 20 Dec 2019 21:56:18 +0000
Headlines moving the stock market in real time.

Dow Jones Today: Data Does It Again
Fri, 20 Dec 2019 21:28:54 +0000
Stocks advanced to close the week amid a slew of favorable economic data points and as President Trump said a formal signing of Phase I of a trade accord between the U.S. and China is being arranged, allaying fears that the agreement would be delayed.Source: Provided by Finviz * The S&P 500 advanced 0.49% * The Dow Jones Industrial Average climbed 0.28% * The Nasdaq Composite tacked on 0.42% * For the second time this week, Merck (NYSE:MRK) was among the best-performing Dow constituents as a bunch of the index's defensive names ralliedImportant consumer data out earlier today indicated that household spending climbed 0.3% last month following a 0.1% increase in October, according to the Commerce Department.Additionally, the University of Michigan consumer sentiment reading for December rose for a fourth straight month while personal incomes gained 0.5% in November, easily beating estimates calling for a 0.3% increase.InvestorPlace – Stock Market News, Stock Advice & Trading Tips * 10 2019 Losers That Will Be 2020 Winners The Commerce Department also said third-quarter GDP increased 2.1%, meaning the revision released earlier today was not altered from the initial reading.Overall, the data look good and that helps stocks, explaining why in late trading, 25 of the 30 Dow components were spotted higher. Merck AgainAs noted above, Merk has been in style this week. Today, the pharmaceuticals name rallied 1.66% after the U.S. Food and Drug Administration (FDA) approved Merck's ERVEBO, a treatment for the deadly Ebola Zaire virus.Approval of this vaccine by the FDA represents another important milestone in the global response to Ebola Virus Disease and stands as a tremendous accomplishment by a unique global partnership," said Dr. Roger M. Perlmutter president, Merck Research Laboratories, in a statement. "In acknowledging this event, I wish in particular to recognize the heroic efforts being made by frontline responders to the ongoing outbreak in the Democratic Republic of the Congo. We are proud and honored to play a role in supporting their vital activities, and we remain focused on the important work ahead." Dialing Up GainsApple (NASDAQ:AAPL) was the Dow's smallest gainer after Piper Jaffray analyst Michael J. Olson was out today reiterating an "overweight" rating on the stock while lifting his price target to $305 from $290, citing expected demand from next year's 5G upgrade cycle."While still three quarters away, the 5G iPhone's integration into the investor narrative around Apple shares is well underway," said the analyst. "We see this as a strong level of interest given limited 5G marketing chatter to date and the high price point used in our survey."Talk of 5G upgrades and Apple could be one reason why Verizon (NYSE:VZ) was tussling with Merck for top honors in the Dow today. Verizon sprinted higher by 2.1% on heavy volume and light news flow. Marvelous MicrosoftMicrosoft (NASDAQ:MSFT) has been one of the Dow's stars this year and while it may not gain another 50% next year, 2020 is still setting up to be a strong year for the mega-cap technology name."Microsoft is increasingly being viewed as a strategic technology partner as evidenced by customers making long-term commitments," said J.P. Morgan analyst Mark Murphy in a note out today.The analyst notes essentially all of Microsoft's revenue growth is organic, indicating the company is offering value to established customers and is getting those customers to add new products and services. Bad ReactionAfter the close of U.S. markets Thursday, Nike (NYSE:NKE) delivered fiscal second-quarter results that beat estimates. The company said it earned 70 cents a share on sales of $10.3 billion. Wall Street was expecting 58 cents per share and revenue of $10.09 billion. * 7 Top-Tier Dividend Stocks for 2020 Investors weren't satisfied though as the stock fell 1.2%. The company forecast revenue growth for the current quarter, which ends in February, of high single digits. More Boeing BadnessThese days, it's hard not to mention Boeing (NYSE:BA) in this space and it's probably even harder to find some good news about the aerospace giant. The shares slid 1.6% Friday on bad news that doesn't pertain to the controversial 737 MAX jet.Rather, Boeing was punished today because the company canceled "plans for its CST-100 Starliner to rendezvous with the International Space Station on the capsule's debut flight, raising doubts over whether the company will be able to ferry astronauts to the orbiting laboratory next year," reports Bloomberg. Bottom Line on the Dow Jones TodayWe're not quite into 2020, but it's never too early for getting a reading on how earnings could shape up in the new year. Right now, the outlook is solid. Whether or not stocks will reflect as much as the calendar turns to 2020 is a different matter."The estimated (year-over-year) earnings growth rate for CY 2020 is 9.6%, which is above the 10-year average (annual) earnings growth rate of 9.1%," according to FactSet research. "All 11 sectors are projected to report year-over-year growth in earnings. Five sectors are predicted to report double-digit growth, led by the Energy, Industrials, and Materials sectors."As of this writing, Todd Shriber did not own any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Vaping Stocks to Get into Ahead of the Crowd * 5 Retail Stocks That Are Winning Big This Holiday Season * Make the Shift Toward Value Stocks With These 5 Picks The post Dow Jones Today: Data Does It Again appeared first on InvestorPlace.

Dow Jones Keeps Hitting Highs; Micron, Nike, FedEx, Boeing, Winnebago In Focus: Weekly Review
Fri, 20 Dec 2019 21:08:09 +0000
The stock market powered to fresh highs this week. Micron and Winnebago were earnings winners while Nike stepped back. Boeing and FedEx woes continued.

Nike’s Jordan brand just had its first billion-dollar quarter
Fri, 20 Dec 2019 20:48:00 +0000
Nike’s iconic Jordan brand just had its first billion-dollar quarter, according to Nike’s outgoing chief executive, Mark Parker. “The Jordan brand, on a wholesale equivalent basis, just earned its first billion-dollar quarter, an incredible milestone, and just as important, it was very high-quality growth,” Parker said on what was his final earnings call before stepping into the executive chairman role. John Donahoe will succeed Parker as CEO, effective Jan. 13.

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.